Presentation of laboratory and Sonoclot variables using principal component analysis: Identification of hypo- and hypercoagulation in the hellp syndrome

被引:5
作者
Liszka-Hackzell J.J. [1 ]
Schött U. [2 ]
机构
[1] Department of Anesthesiology, University of Arizona, Tucson, AZ 85724
[2] Halmstad County Hospital, Dept. of Anesthesiol./Intensive Care, County Hospital Halmstad, Halmstad
关键词
HELLP syndrome; Principal component analysis;
D O I
10.1007/s10877-005-9046-0
中图分类号
学科分类号
摘要
The HELLP (Hemolysis, Elevated Liver enzyme, and Low Platelet) syndrome requires close monitoring of rapid changes in hemostasis. A bedside viscoelastic test - Sonoclot - was used together with coagulation, liver and hemolysis laboratory analyses in three parturients with the HELLP syndrome up to 10 days postpartum. Principal component analysis (PCA) was used to reduce the dimensionality of this multivariate problem and to visualize this process in a two-dimensional plot. It was possible to follow changes in these variables over time and to show how they changed in relation to 10 typical healthy parturients with normal laboratory and Sonoclot values as well as 20 simulated patients with hypo- or hypercoagubility. The effects of emergency delivery, correction of low plasma-antithrombin with plasma and antithrombin factor concentrate, plasma exchange and individualized dosages of low molecular weight heparin to counteract postpartum Sonoclot detected hypercoagulation were evaluated. The efficiency of each treatment strategy was visualized in the PCA plot by movement towards an area with normocoagulation. In conclusion, PCA of viscoelastic and laboratory coagulation analysis data facilitated the detection of both hypo- and hypercoagulative events and represents an alternative way to evaluate treatment strategies in patients with complex coagulative disorders, like the HELLP syndrome. © Springer Science + Business Media, Inc. 2005.
引用
收藏
页码:247 / 252
页数:5
相关论文
共 14 条
[1]  
Sibai B.M., Ramadan M.K., Usta I., Et al., Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome), Am. J. Obstet. Gynecol., 169, pp. 1000-1063, (1993)
[2]  
Fish R., The HELLP syndrome: Case report and review of the literature, J. Emerg. Med., 11, pp. 169-174, (1993)
[3]  
Stevenson J.T., Graham D.J., Hepatic hemorrhage and the HELLP syndrome: A surgeon's perspective, Am. Surgeon, 61, pp. 756-760, (1995)
[4]  
Barton J.R., Riely C.A., Adamec T.A., Et al., Hepatic histopathology condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis elevated liver enzymes, and low platelet count), Am. J. Obstet. Gynecol., 167, pp. 1538-1543, (1992)
[5]  
Steer P.L., Krantz H.B., Thromboelastography and Sonoclot analysis in the healthy parturient, J. Clin. Anesth., 5, pp. 419-424, (1993)
[6]  
Whitta R.K., Cox D.J., Mallet S.V., Thrombelastography reveals two causes of haemorrhage in HELLP syndrome, Br. J. Anaesth., 74, pp. 464-468, (1995)
[7]  
Wong C.A., Liu S., Glassenberg R., Comparison of thrombelastography with common coagulation tests in preeclamptic and healthy parturients, Reg. Anesth., 20, pp. 521-527, (1995)
[8]  
Orlikowski C.E.P., Rocke D.A., Murray W.B., Et al., Thrombelastography changes in pre-eclampsia and eclampsia, Br. J. Anesth., 77, pp. 157-161, (1996)
[9]  
Steer P.L., Finley B.E., Blumenthal L.A., Abruptio placentae and disseminated intravascular coagulation: Use of thrombelastography and sonoclot analysis, Int. J. Obstet. Anesth., 3, pp. 229-233, (1994)
[10]  
Kjellberg U., Hellgren M., Sonoclot signature during normal pregnancy, Int. Care Med., 26, pp. 206-211, (2000)